Mao P, Cohen O, Kowalski KJ, Kusiel J, et al. Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer. Clin Cancer Res 2020 Jul 28. pii: 1078-0432.CCR-19-3958.
PMID: 32723837